3D Bioprinting Market

3D Bioprinting Market Insights

"The global 3D bioprinting market was estimated at USD 1.5 billion in 2022 and is likely to grow at a CAGR of 19.82% during 2023-2028 to reach USD 4.44 billion in 2028."

Want to get a free sample? Register Here

Introduction

3D bioprinting is a form of additive manufacturing that utilizes 3D printing to fabricate biomedical parts that maximally imitate natural tissue characteristics. This printing utilizes the layer-by-layer method to deposit materials called bio-inks, to create tissue-like structures which are later used in tissue and medical engineering fields.

3D Bioprinting Market Dynamics

3D Bioprinting Market Drivers

The limited number of organ donors and an increasingly senior population with chronic respiratory diseases are expected to boost the demand for 3D bioprinting market

Some other factors augmenting the market growth are-

• There is a growing need for organ transplants, with the use of 3D bioprinting, it may be possible to produce organs and tissues that are unique to a patient. The advancement of 3D bioprinting technology has seen a rise in financial support and research for the development of 3D bioprinting.

• The development of new 3D printing materials, software, and hardware have made it possible to print biological materials in greater detail and accuracy.

• The opportunity for 3D bioprinting to transform patient care has led to increasing interest in the healthcare sector. In addition, this has the potential to develop personalized medicine, and a reduction in animal experimentation is another benefit of the technology.

• Increasing interest of investors, private businesses, governments, and academic institutions have all made considerable investments in the 3D bioprinting sector. 

Moreover, a surge in public and private funding to support bioprinting research activities further offers immense growth opportunities to the industry players in the coming years.

3D Bioprinting Market Opportunities

• Patient-specific tissue-engineered implants represent a multi-billion dollar opportunity as healthcare shifts toward personalized regenerative medicine solutions.

• Pharmaceutical testing on bioprinted human tissue models reduces drug development costs by eliminating nearly 70% of failed animal trials before reaching human testing phases.

• On-demand bioprinted skin grafts for burn victims dramatically accelerate healing times while reducing rejection rates compared to traditional donor-dependent approaches.

• Specialized bioinks incorporating stem cells and growth factors command premium pricing with nearly 85% gross margins as the enabling technology for complex tissue fabrication.

• Academic-industry partnerships focused on organ printing breakthroughs are attracting unprecedented venture capital with over $800M invested in early-stage development programs during 2024 alone.

COVID-19 Impact 

The COVID-19 outbreak has positively influenced the 3D bioprinting industry. The pandemic has turned the lives of people worldwide, with the number of cases increasing rapidly. The pandemic resulted in an increasing number of coronavirus patients across the globe, putting a strain on the healthcare sector with limited hospital staff. Hence, as a reaction to the increasing cases of coronavirus, several 3D bioprinting companies are responding to the crises by offering their respective skills to ease the burden on the supply chain and governments. Due to the ever-increasing COVID-19 cases, the demand for 3D bioprinters is surging and the market for 3D bioprinting.

Key Players

The following are the key players in the 3D bioprinting market:

• 3D Systems Corporation (US)

• Aspect Biosystems Ltd (Canada)

• GeSIM GmbH (Germany)

• Allevi Inc. (US)

• Cyfuse Biomedical KK (Japan)

• Envision TEC GmbH (Germany)

• Organovo Holdings Inc. (US)

• RegenHU SA (Switzerland)

• Stratasys Ltd (US)

• REGEMAT 3D (Spain)

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

Segment Analysis

Application Trends

"The demand for medical pills is rising as the number of pharmaceutical sector participants grows."

The widespread use of prescription tablets to treat a variety of chronic ailments is driving the expansion of the global 3D bioprinting market. Furthermore, the increased need for medications and the cost-effective application of bio-drugs employing this technology is propelling the industry forward.

The demand for medical pills is rising as the number of pharmaceutical sector participants grows. Millions of individuals throughout the world utilize capsules and medical pills regularly. As a result, this category is likely to increase at a rapid pace over the forecast period.

Component Trends

"3D Bioprinters accounted for the largest market share during the forecast period."

The market is classified into 3D Bioprinter, Biomaterial, and Scaffolds. 3D Bioprinters accounted for the largest market share during the forecast period. Factors such as technological advancements and growing demand for organ transplants are driving the growth of the market.

Want to get a free sample? Register Here

Technology Trends

"Inkjet-based segment share more than 35% in 2022, magnetic levitation segment is projected to expand with the fastest CAGR of nearly 14% during the forecast period."

The 3D bioprinting market is classified into inkjet-based, magnetic levitation, syringe-based, laser-based, and others. Inkjet-based segment share more than 35% in 2022, magnetic levitation segment is projected to expand with the fastest CAGR of nearly 14% during the forecast period. This is mainly ascribed to its ability to print complex living organs or tissues on the culture substrates with the help of biomaterials, such as bio-inks, which bolsters segment growth.

Regional Insights

"North America shares more than 30% in 2022 and is expected to lead throughout the forecast period."

North America shares more than 30% in 2022 and is expected to lead throughout the forecast period and Asia Pacific is the fastest-growing market with shares of more than 20% in 2022. This is mainly attributed to a growing demand for 3D bioprinting as this technology has been reconnoitered for drug testing and organ transplantation. Also, the highly advanced healthcare industry, presence of major market players, robust research & development infrastructure, growing awareness of 3D Bioprinting, and technological developments in the region, further proliferate the regional market growth.

Want to get a free sample? Register Here

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market. The following are the key features of the report:

• Market structure: Overview, industry life cycle analysis, supply chain analysis.

• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.

• Market trend and forecast analysis.

• Market segment trend and forecast.

• Competitive landscape and dynamics: Market share, Service portfolio, New Product Launches, etc.

• COVID-19 impact and its recovery curve

• Attractive market segments and associated growth opportunities.

• Emerging trends.

• Strategic growth opportunities for the existing and new players.

• Key success factors.

Market Segmentation

This report studies the market covering 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

The 3D bioprinting market is segmented into the following categories:

By Technology Type

• Inkjet-based

• Magnetic Levitation

• Syringe-based

• Laser-base

• Others

By Component Type

• 3D Bioprinters

• Biomaterials

• Scaffolds

By Application Type

• Medical [Tissue and organ generation, Medical pills, Prosthetics, and implants]

• Dental

• Biosensors

• Consumer/Personal Product Testing

• Bioinks

• Food & Animal Products

By Region

• North America (Country Analysis: The USA, Canada, and Mexico)

• Europe (Country Analysis: Germany, France, The UK, Russia, and the Rest of Europe)

• Asia-Pacific (Country Analysis: China, India, Australia, South Korea, and the Rest of Asia-Pacific)

• Rest of the World (Country Analysis: Saudi Arabia, Brazil, and Others)

Research Methodology

This strategic assessment report, from Stratview Research, provides a comprehensive analysis that reflects today’s 3D bioprinting market realities and future market possibilities for the forecast period. The report segments and analyzes the market in the most detailed manner to provide a panoramic view of the market. The vital data/information provided in the report can play a crucial role for market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate growth strategies to expedite their growth process.

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)

• SWOT analysis of key players (up to three players)

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com